125 related articles for article (PubMed ID: 8957636)
21. Ectopic ACTH syndrome due to occult bronchial carcinoid.
Corsello SM; Fintini D; Lovicu RM; Paragliola RM; Rufini V; Simonetti G; Pontecorvi A
Clin Nucl Med; 2009 Jul; 34(7):459-61. PubMed ID: 19542957
[No Abstract] [Full Text] [Related]
22. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy.
Chen CC; Czerwiec FS; Feuillan PP
J Nucl Med; 1998 Feb; 39(2):238-40. PubMed ID: 9476926
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor imaging in small cell lung cancer.
Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
[TBL] [Abstract][Full Text] [Related]
24. What is a false-positive somatostatin receptor scintigraphy?
Reubi JC
J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
[No Abstract] [Full Text] [Related]
25. Clinical experience with somatostatin receptor imaging in lymphoma.
Bong SB; VanderLaan JG; Louwes H; Schuurman JJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):46-50. PubMed ID: 7992081
[No Abstract] [Full Text] [Related]
26. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
27. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
28. Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy.
Cormack J
Eur J Nucl Med; 1998 Apr; 25(4):442-4. PubMed ID: 9643971
[No Abstract] [Full Text] [Related]
29. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Krenning EP; Kooij PP; Bakker WH; Breeman WA; Postema PT; Kwekkeboom DJ; Oei HY; de Jong M; Visser TJ; Reijs AE
Ann N Y Acad Sci; 1994 Sep; 733():496-506. PubMed ID: 7978900
[No Abstract] [Full Text] [Related]
30. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M
J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472
[TBL] [Abstract][Full Text] [Related]
31. [Incidental diagnosis of lymph node tuberculosis in an 111-indium-octreotide scintigraphy during a study of acromegaly].
Tabuenca Dopico O; Gutiérrez Mendiguchía C; Rego Iraeta A
Rev Esp Med Nucl; 2006; 25(3):193-7. PubMed ID: 16762275
[TBL] [Abstract][Full Text] [Related]
32. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
33. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
34. Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan.
Winter PF; Lapke J; Winek R
J Nucl Med; 1996 Sep; 37(9):1516-7. PubMed ID: 8790204
[TBL] [Abstract][Full Text] [Related]
35. Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Busse F; Führer D; Stumvoll M; Schneider JP; Neid M; Kluge R; Sterker I
Thyroid; 2008 Nov; 18(11):1237-8. PubMed ID: 18925841
[No Abstract] [Full Text] [Related]
36. Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.
Matte J; Roufosse F; Rocmans P; Schoutens A; Jacobovitz D; Mockel J
Postgrad Med J; 1998 Feb; 74(868):108-10. PubMed ID: 9616493
[TBL] [Abstract][Full Text] [Related]
37. Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.
Fjälling M; Andersson P; Forssell-Aronsson E; Grétarsdóttir J; Johansson V; Tisell LE; Wängberg B; Nilsson O; Berg G; Michanek A; Lindstedt G; Ahlman H
J Nucl Med; 1996 Sep; 37(9):1519-21. PubMed ID: 8790206
[TBL] [Abstract][Full Text] [Related]
38. Scintigraphic imaging of sarcomatous tumors with [(111)In-DTPA-phe-1]-octreotide.
Giannakenas C; Kalofonos HP; Apostolopoulos D; Petsas T; Kalogeropoulou C; Tzorakelefterakis E; Skopa CD; Vassilakos PJ
Oncology; 2000; 58(1):18-24. PubMed ID: 10644936
[TBL] [Abstract][Full Text] [Related]
39. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
40. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]